Publicacions destacades
-
The Endothelium as a Driver of Liver Fibrosis and Regeneration
Autors:Referència: Cells 2020. -
Aging Influences Hepatic Microvascular Biology and Liver Fibrosis in Advanced Chronic Liver Disease
Autors:Referència: Aging and Disease 2019. -
Simvastatin Prevents Progression of Acute on Chronic Liver Failure in Rats With Cirrhosis and Portal Hypertension.
Autors:Referència: GASTROENTEROLOGY 2018. -
Mitochondria-targeted antioxidant mitoquinone deactivates human and rat HSC and reduces portal hypertension in cirrhotic rats.
Autors:Referència: LIVER INTERNATIONAL 2017. -
Enoxaparin reduces hepatic vascular resistance and portal pressure in cirrhotic rats
Autors:Referència: JOURNAL OF HEPATOLOGY 2016. -
Simvastatin prevents the aggravation of hepatic microvascular dysfunction caused by endotoxemia in cirrhotic rats
Autors:Referència: HEPATOLOGY 2015. -
Metformin reduces hepatic resistance and portal pressure in cirrhotic rats
Autors:Referència: AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY 2015.
